{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:45:23Z","timestamp":1786592723540,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003511"],"award-info":[{"award-number":["82003511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Discipline and Platform Construction Project of Center for AIDS Research, Wuhan University","award":["PTPP2023002"],"award-info":[{"award-number":["PTPP2023002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88530-2","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:44:51Z","timestamp":1738435491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The sex differences in diseases progression and prognosis among persons with HIV and HBV coinfection"],"prefix":"10.1038","volume":"15","author":[{"given":"Rongrong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"14","key":"88530_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra065142","volume":"356","author":"MJ Koziel","year":"2007","unstructured":"Koziel, M. J. & Peters, M. G. Viral hepatitis in HIV infection. N Engl. J. Med. 356(14), 1445\u20131454. https:\/\/doi.org\/10.1056\/NEJMra065142 (2007).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"88530_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QAI.0b013e31816de23c","volume":"48","author":"Y Rong-Rong","year":"2008","unstructured":"Rong-Rong, Y., Xi-En, G., Shi-Cheng, G. & Yong-Xi, Z. Interaction of hepatitis B and C viruses in patients infected with HIV. J. Acquir. Immune Defic. Syndr. 48(4), 505\u2013506. https:\/\/doi.org\/10.1097\/QAI.0b013e31816de23c (2008).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88530_CR3","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","volume":"31","author":"KP Singh","year":"2017","unstructured":"Singh, K. P. et al. HIV-hepatitis B virus coinfection: Epidemiology, pathogenesis, and treatment. AIDS 31, 2035\u20132052. https:\/\/doi.org\/10.1097\/QAD.0000000000001574 (2017).","journal-title":"AIDS"},{"key":"88530_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12879-017-2568-5","volume":"17","author":"PA Coffie","year":"2017","unstructured":"Coffie, P. A. et al. Prevalence of hepatitis B and delta according to HIV-type: A multi-country cross-sectional survey in West Africa. BMC Infect. Dis. 17, 466. https:\/\/doi.org\/10.1186\/s12879-017-2568-5 (2017).","journal-title":"BMC Infect. Dis."},{"issue":"9349","key":"88530_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/s0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio, C. L. et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360(9349), 1921\u20131926. https:\/\/doi.org\/10.1016\/s0140-6736(02)11913-1 (2002).","journal-title":"Lancet"},{"issue":"7","key":"88530_CR6","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/biology12070984","volume":"12","author":"R Nevola","year":"2023","unstructured":"Nevola, R. et al. Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma. Biology (Basel) 12(7), 984. https:\/\/doi.org\/10.3390\/biology12070984 (2023).","journal-title":"Biology (Basel)"},{"issue":"3","key":"88530_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"88530_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/apt.15917","volume":"52","author":"NE Rich","year":"2020","unstructured":"Rich, N. E. et al. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment. Pharmacol. Ther. 52(4), 701\u2013709. https:\/\/doi.org\/10.1111\/apt.15917 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"88530_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.ph.45.030183.000345","volume":"45","author":"AK Roy","year":"1983","unstructured":"Roy, A. K. & Chatterjee, B. Sexual dimorphism in the liver. Annu. Rev. Physiol. 45, 37\u201350. https:\/\/doi.org\/10.1146\/annurev.ph.45.030183.000345 (1983).","journal-title":"Annu. Rev. Physiol."},{"key":"88530_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/135965350701200116","volume":"12","author":"GV Matthews","year":"2007","unstructured":"Matthews, G. V., Cooper, D. A. & Dore, G. J. Improvements in parameters of end-stage liver disease in patients with HIV\/HBV-related cirrhosis treated with tenofovir. Antivir. Ther. 12, 119\u2013122 (2007).","journal-title":"Antivir. Ther."},{"key":"88530_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325. https:\/\/doi.org\/10.1002\/hep.21178 (2006).","journal-title":"Hepatology"},{"issue":"1","key":"88530_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard, A. et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection comparison with liver biopsy and fibrotest. Hepatology 46(1), 32\u201336. https:\/\/doi.org\/10.1002\/hep.21669 (2007).","journal-title":"Hepatology"},{"issue":"7","key":"88530_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1365-3156.2009.02290.x","volume":"14","author":"M Cornell","year":"2009","unstructured":"Cornell, M., Myer, L., Kaplan, R., Bekker, L. G. & Wood, R. The impact of gender and income on survival and retention in a south African antiretroviral therapy programme. Trop. Med. Int. Health 14(7), 722\u2013731 (2009).","journal-title":"Trop. Med. Int. Health"},{"key":"88530_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijid.2014.11.009","volume":"30","author":"KC Takarinda","year":"2015","unstructured":"Takarinda, K. C. et al. Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007\u20132010. Int. J. Infect. Dis. 30, 98\u2013105 (2015).","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"88530_CR15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1186\/s12889-021-11050-x","volume":"21","author":"Z Lu","year":"2021","unstructured":"Lu, Z. et al. Analysis on the trend of AIDS incidence in Zhejiang, China based on the age-period-cohort model (2004\u20132018). BMC Public Health 21(1), 1077 (2021).","journal-title":"BMC Public Health"},{"issue":"10","key":"88530_CR16","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/QAD.0000000000001080","volume":"30","author":"J Audsley","year":"2016","unstructured":"Audsley, J. et al. Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity. AIDS 30(10), 1597\u20131606. https:\/\/doi.org\/10.1097\/QAD.0000000000001080 (2016).","journal-title":"AIDS"},{"issue":"5","key":"88530_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000002386","volume":"84","author":"J Audsley","year":"2020","unstructured":"Audsley, J. et al. Long-term TDF-inclusive ART and progressive rates of HBsAg loss in HIV-HBV coinfection-lessons for functional HBV cure?. J. Acquir. Immune Defic. Syndr. 84(5), 527\u2013533. https:\/\/doi.org\/10.1097\/QAI.0000000000002386 (2020).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"88530_CR18","first-page":"559","volume":"30","author":"AM Wensing","year":"2022","unstructured":"Wensing, A. M. et al. 2022 update of the drug resistance mutations in HIV-1. Top Antivir. Med. 30(4), 559\u2013574 (2022).","journal-title":"Top Antivir. Med."},{"key":"88530_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","volume":"6","author":"YF Liaw","year":"2012","unstructured":"Liaw, Y. F. et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update. Hepatol. Int. 6, 531\u2013561. https:\/\/doi.org\/10.1007\/s12072-012-9365-4 (2012).","journal-title":"Hepatol. Int."},{"key":"88530_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1440-1746.2008.05382.x","volume":"23","author":"DM Iser","year":"2008","unstructured":"Iser, D. M. & Sasadeusz, J. J. Current treatment of HIV\/hepatitis B virus coinfection. J. Gastroenterol. Hepatol. 23, 699\u2013706. https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05382.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"88530_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/01.aids.0000218550.85081.59","volume":"20","author":"GV Matthews","year":"2006","unstructured":"Matthews, G. V. et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS 20, 863\u2013870. https:\/\/doi.org\/10.1097\/01.aids.0000218550.85081.59 (2006).","journal-title":"AIDS"},{"issue":"10","key":"88530_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/QAD.0000000000000686","volume":"29","author":"CL Thio","year":"2015","unstructured":"Thio, C. L. et al. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: Outcomes through 144 weeks. AIDS 29(10), 1173\u20131182. https:\/\/doi.org\/10.1097\/QAD.0000000000000686 (2015).","journal-title":"AIDS"},{"issue":"1","key":"88530_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000000927","volume":"72","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Lamivudine monotherapy-based cART is efficacious for HBV treatment in HIV\/HBV coinfection when baseline HBV DNA <20,000 IU\/mL. J. Acquir. Immune Defic. Syndr. 72(1), 39\u201345. https:\/\/doi.org\/10.1097\/QAI.0000000000000927 (2016).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88530_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/QAD.0b013e32835a9984","volume":"27","author":"CL Thio","year":"2010","unstructured":"Thio, C. L. et al. Characterization of HIV-HBV coinfeciton in a multinational HIV-infected cohort. AIDS 27, 191\u2013201. https:\/\/doi.org\/10.1097\/QAD.0b013e32835a9984 (2010).","journal-title":"AIDS"},{"key":"88530_CR25","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1086\/605675","volume":"49","author":"J Idoko","year":"2009","unstructured":"Idoko, J. et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin. Infect. Dis. 49, 1268\u20131273. https:\/\/doi.org\/10.1086\/605675 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"88530_CR26","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1086\/593104","volume":"47","author":"CJ Hoffmann","year":"2008","unstructured":"Hoffmann, C. J. et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin. Infect. Dis. 47, 1479\u20131485. https:\/\/doi.org\/10.1086\/593104 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"88530_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074900","volume":"8","author":"P Ive","year":"2013","unstructured":"Ive, P. et al. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV\/HBV co-infection in a South African HIV clinical trial. PLoS One 8, e74900. https:\/\/doi.org\/10.1371\/journal.pone.0074900 (2013).","journal-title":"PLoS One"},{"key":"88530_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2893.2008.00970.x","volume":"15","author":"JT Blackard","year":"2008","unstructured":"Blackard, J. T. & Sherman, K. E. HCV\/HIV co-infection: time to re-evaluate the role of HIV in the liver?. J. Viral Hepat. 15, 323\u2013330. https:\/\/doi.org\/10.1111\/j.1365-2893.2008.00970.x (2008).","journal-title":"J. Viral Hepat."},{"key":"88530_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/hep.23679","volume":"52","author":"AC Tuyama","year":"2010","unstructured":"Tuyama, A. C. et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV\/hepatitis C virus-induced liver fibrosis. Hepatology 52, 612\u2013622. https:\/\/doi.org\/10.1002\/hep.23679 (2010).","journal-title":"Hepatology"},{"issue":"6","key":"88530_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/infdis\/jir885","volume":"205","author":"JC Price","year":"2012","unstructured":"Price, J. C. et al. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J. Infect. Dis. 205(6), 1005\u20131013. https:\/\/doi.org\/10.1093\/infdis\/jir885 (2012).","journal-title":"J. Infect. Dis."},{"issue":"7","key":"88530_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3851\/IMP1649","volume":"15","author":"A Boyd","year":"2010","unstructured":"Boyd, A. et al. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use. Antivir. Ther. 15(7), 963\u2013974. https:\/\/doi.org\/10.3851\/IMP1649 (2010).","journal-title":"Antivir. Ther."},{"issue":"11","key":"88530_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259073","volume":"16","author":"NM Ngongo","year":"2021","unstructured":"Ngongo, N. M. et al. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006\u20132017. PLoS One 16(11), e0259073. https:\/\/doi.org\/10.1371\/journal.pone.0259073 (2021).","journal-title":"PLoS One"},{"issue":"1","key":"88530_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12879-018-3204-8","volume":"18","author":"HN Luma","year":"2018","unstructured":"Luma, H. N. et al. Late presentation to HIV\/AIDS care at the Douala general hospital, Cameroon: Its associated factors, and consequences. BMC Infect. Dis. 18(1), 298. https:\/\/doi.org\/10.1186\/s12879-018-3204-8 (2018).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"88530_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12879-019-3826-5","volume":"19","author":"NA Benzekri","year":"2019","unstructured":"Benzekri, N. A. et al. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa. BMC Infect. Dis. 19(1), 261. https:\/\/doi.org\/10.1186\/s12879-019-3826-5 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"88530_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001290","volume":"9","author":"TB Campbell","year":"2012","unstructured":"Campbell, T. B. et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: A randomized clinical trial in diverse multinational settings. PLoS Med. 9(8), e1001290. https:\/\/doi.org\/10.1371\/journal.pmed.1001290 (2012).","journal-title":"PLoS Med."},{"key":"88530_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0002-9343(96)00077-0","volume":"101","author":"RD Moore","year":"1996","unstructured":"Moore, R. D., Fortgang, I., Keruly, J. & Chaisson, R. E. Adverse events from drug therapy for human immunodeficiency virus disease. Am. J. Med. 101, 34\u201340. https:\/\/doi.org\/10.1016\/s0002-9343(96)00077-0 (1996).","journal-title":"Am. J. Med."},{"key":"88530_CR37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00126334-200008010-00003]","volume":"24","author":"JS Currier","year":"2000","unstructured":"Currier, J. S. et al. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The AIDS Clinical Trials Group 175 Team. J. Acquir. Immune Defic. Syndr. 24, 316\u2013324. https:\/\/doi.org\/10.1097\/00126334-200008010-00003] (2000).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88530_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2165\/00002018-200528120-00003","volume":"28","author":"R Clark","year":"2005","unstructured":"Clark, R. Sex differences in antiretroviral therapy-associated intolerance and adverse events. Drug Saf. 28, 1075\u20131083. https:\/\/doi.org\/10.2165\/00002018-200528120-00003 (2005).","journal-title":"Drug Saf."},{"key":"88530_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/s1054-139x(94)90628-9","volume":"15","author":"CV Fletcher","year":"1994","unstructured":"Fletcher, C. V., Acosta, E. P. & Strykowski, J. M. Gender differences in human pharmacokinetics and pharmacodynamics. J. Adolesc. Health 15, 619\u2013629. https:\/\/doi.org\/10.1016\/s1054-139x(94)90628-9 (1994).","journal-title":"J. Adolesc. Health"},{"key":"88530_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF00315510","volume":"45","author":"CA Knupp","year":"1993","unstructured":"Knupp, C. A., Milbrath, R. L. & Barbhaiya, R. H. Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients. Eur. J. Clin. Pharmacol. 45, 409\u2013413. https:\/\/doi.org\/10.1007\/BF00315510 (1993).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"88530_CR41","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016]","volume":"130","author":"UH Iloeje","year":"2006","unstructured":"Iloeje, U. H. et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130, 678\u2013686. https:\/\/doi.org\/10.1053\/j.gastro.2005.11.016] (2006).","journal-title":"Gastroenterology"},{"key":"88530_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen, C. J. et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 295, 65\u201373. https:\/\/doi.org\/10.1001\/jama.295.1.65 (2006).","journal-title":"JAMA."},{"key":"88530_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/gut.2008.157735","volume":"58","author":"GL Wong","year":"2009","unstructured":"Wong, G. L. et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 58, 111\u20131117. https:\/\/doi.org\/10.1136\/gut.2008.157735 (2009).","journal-title":"Gut."},{"key":"88530_CR44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/apc.2014.0079","volume":"28","author":"SK Schwarcz","year":"2014","unstructured":"Schwarcz, S. K., Vu, A., Hsu, L. C. & Hessol, N. A. Changes in causes of death among persons with AIDS: San Francisco, California, 1996\u20132011. AIDS Patients Care 28, 517\u2013523. https:\/\/doi.org\/10.1089\/apc.2014.0079 (2014).","journal-title":"AIDS Patients Care"},{"key":"88530_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2012.06.010","volume":"57","author":"V Hernando","year":"2012","unstructured":"Hernando, V. et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection. J. Hepatol. 57, 743\u2013751. https:\/\/doi.org\/10.1016\/j.jhep.2012.06.010 (2012).","journal-title":"J. Hepatol."},{"key":"88530_CR46","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","volume":"2","author":"S Croxford","year":"2017","unstructured":"Croxford, S. et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health 2, e35\u2013e46. https:\/\/doi.org\/10.1016\/S2468-2667(16)30020-2 (2017).","journal-title":"Lancet Public Health"},{"key":"88530_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25031","volume":"21","author":"AC Pettit","year":"2018","unstructured":"Pettit, A. C. et al. Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. J. Int. AIDS Soc. 21, e25031. https:\/\/doi.org\/10.1002\/jia2.25031 (2018).","journal-title":"J. Int. AIDS Soc."},{"key":"88530_CR48","doi-asserted-by":"publisher","first-page":"e0196057","DOI":"10.1371\/journal.pone.0196057]","volume":"13","author":"D Mak","year":"2018","unstructured":"Mak, D., Babb de Villiers, C., Chasela, C., Urban, M. I. & Kramvis, A. Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000\u20132012. PLoS One 13, e0196057. https:\/\/doi.org\/10.1371\/journal.pone.0196057] (2018).","journal-title":"PLoS One"},{"key":"88530_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/hep.25800","volume":"57","author":"GN Ioannou","year":"2013","unstructured":"Ioannou, G. N. et al. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology 57, 249\u2013257. https:\/\/doi.org\/10.1002\/hep.25800 (2013).","journal-title":"Hepatology"},{"key":"88530_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/QAD.0000000000001422","volume":"31","author":"DJ Pinato","year":"2017","unstructured":"Pinato, D. J., Dalla Pria, A., Sharma, R. & Bower, M. Hepatocellular carcinoma: An evolving challenge in viral hepatitis and HIV coinfection. AIDS 31, 603\u2013611. https:\/\/doi.org\/10.1097\/QAD.0000000000001422 (2017).","journal-title":"AIDS"},{"key":"88530_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-030-03502-0_9","volume":"177","author":"J Hu","year":"2019","unstructured":"Hu, J., Liu, K. & Luo, J. HIV-HBV and HIV-HCV coinfection and liver cancer development. Cancer Treat. Res. 177, 231\u2013250. https:\/\/doi.org\/10.1007\/978-3-030-03502-0_9 (2019).","journal-title":"Cancer Treat. Res."},{"issue":"10","key":"88530_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/hiv.12937","volume":"21","author":"M Taborelli","year":"2020","unstructured":"Taborelli, M. et al. Excess liver-related mortality among people with AIDS compared to the general population: an Italian nationwide cohort study using multiple causes of death. HIV Med. 21(10), 642\u2013649. https:\/\/doi.org\/10.1111\/hiv.12937 (2020).","journal-title":"HIV Med."},{"issue":"12","key":"88530_CR53","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/09540121.2016.1191608","volume":"28","author":"MD Lima","year":"2016","unstructured":"Lima, M. D., Firmo, A. A. & Martins-Melo, F. R. Trends in AIDS-related mortality among people aged 60 years and older in Brazil: A nationwide population-based study. AIDS Care 28(12), 1533\u20131540. https:\/\/doi.org\/10.1080\/09540121.2016.1191608 (2016).","journal-title":"AIDS Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88530-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88530-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88530-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:44:58Z","timestamp":1738435498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88530-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88530"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88530-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The protocol was approved by the Institutional Review Board of Zhongnan Hospital of Wuhan University. Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"4018"}}